TrialPath
Recruiting

Italian Study of Patients With Lymphoma

NCT06814925 · IRCCS Azienda Ospedaliero-Universitaria di Bologna
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Italian Prospective Observational Cohort Study of Patients With Lymphoma
About this study
The study is aimed at enriching the data on the prognostic role of genetic and epidemiological factors associated with clinical and epidemiological data of patients; to identify factors that influence the evolution of the disease, such as lifestyle and occupational factors, as well as the type of treatment; to document the impact of the disease on quality of life and to provide a platform for future research projects. Study-specific questionnaires will be administered to patients, both at baseline and during follow-up, which methodologically represent a useful tool in order to achieve these objectives.
Eligibility criteria
Inclusion Criteria: * Age greater than or equal to 18 years at enrollment * Diagnosis of lymphoma within 3 months of enrollment * Patients may have been treated, as long as the initial diagnosis of lymphoma is within 3 months of enrollment * Signing of the informed consent form Exclusion Criteria: * none
Study design
Enrollment target: 1500 participants
Age groups: adult, older_adult
Timeline
Starts: 2021-12-07
Estimated completion: 2026-08
Last updated: 2025-02-07
Primary outcomes
  • Overall Survival (OS) (through study completion, an average of 5 years)
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna · other
Contacts & investigators
ContactPier Luigi Zinzani, MD · contact · pierluigi.zinzani@unibo.it · +390512143680
ContactCinzia Pellegrini, MD · contact · cinzia.pellegrini@aosp.bo.it · +390512143680
InvestigatorPier Luigi Zinzani, MD · principal_investigator, IRCCS Azienda Ospedaliero-Universitaria di Bologna
All locations (1)
IRCCS Azienda Ospedaliero - Universitaria di BolognaRecruiting
Bologna, Bologna, Italy